Reading OKUR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track OKUR free→Reading OKUR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track OKUR free→QuarterlyIQ Insights · OKUR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. OnKure Therapeutics, Inc. (the “Company”) amended and restated its 2024 Equity Incentive Plan (the “A&R 2024 Plan”), effective as of June 3, 2026 upon approval by the stockholders of the Company at the Annual Meeting (as defined below). The amendments to the Company’s 2024 Equity Incentive Plan included (1) a one-time increase to the number of shar…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.